Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A sigh of relief for Boston, as Cameron's leadless ICD gets FDA panel thumbs up

This article was originally published in Clinica

Executive Summary

An FDA advisory panel has voted in favour of Cameron Health's subcutaneous implantable cardioverter defibrillator (S-ICD), paving the way for its approval in the US. The positive panel decision is somewhat surprising; earlier this week the agency released a report flagging up a risk of infection and inappropriate shocks with the device.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts